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Dengue virus (DENV) serotypes possess various types from DENV-1 
to DENV-4 that are enveloped viruses belong to the genus Flavivirus of the 
Flaviviridae. Dengue vaccine or antiviral has not yet been clinically approved 
for humans, even though there have been significant efforts toward this end. 
Antiviral activity against DENV is needed to develop to be an alternative 
drug for the DENV virus. Cobalt(II) chloride has been used in the treatment 
and prevention of diseases of humans since ancient times. This study aimed 
to investigate the antiviral effects and Cytotoxicity of Cobalt(II) chloride. 
This compound was further investigated for its inhibitory effect on the 
replication of DENV-1 in Vero cells. The antiviral activity and cytotoxic was 
measured by WST-1 assay. The IC50 value of the Cobalt(II) chloride for DENV-
1 was 0.38 μg/ml. The cytotoxicity of Cobalt(II) chloride to Vero cell suggests 
that the CC50 value was 2.91 µg/ml. The results of this study demonstrate the 
anti-dengue serotype 1 inhibitory activity of Cobalt(II) chloride was highly 
toxic. 
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INTRODUCTION 
Dengue virus (DENV) is a positive-sense 
RNA virus replicating in the membranous 
compartments of cytoplasm. Viral infection induces 
the dengue virus with significant human viral 
pathogens transmitted by Aedes aegypti. Moreover, 
about 50 million infections occur each year, and 
over 2.5 billion people at risk (Gubler, 2002). There 
are four serotypes of the dengue virus. Four 
serotypes of dengue virus: DENV-1, DENV-2, DENV-
3, and DENV-4) are transmitted by the vector 
mosquitoes such as Aedes aegypti and Aedes 
albopictus (Halstead, 2015). Vaccines have been 
developed for DENV infection (Woodland, 2015). 
Recently, WHO immunization group (Strategic 
Advisory Group of Experts; SAGE) has 
recommended the use of partially effective dengue 
vaccine (a live attenuated tetravalent dengue 
vaccine developed by Sanofi Pasteur; CYD-TDV, 
named Dengvaxia) that has been licensed and used 
in 11 countries including Brazil, Mexico, Singapore, 
Thailand and Indonesia (Aguiar et al., 2016). 
Nevertheless, control of the dengue virus through 
the use of vaccination has proved to be elusive 
(Burke et al., 2001). A new approach to controlling 
DENV infection is needed. Antiviral activity of 
DENV is required to develop an alternative drug for 
the dengue virus. The reason caused by the 
alternative drug is not an effective antiviral 
treatment for DENV, and the patient is not 
supportively-treated with any specific treatment 
measures (Zandi et al., 2011).  
Cobalt(II)  chloride is  an inorganic  
compound of cobalt and chlorine, with the formula 
CoCl2. It is usually supplied as the hexahydrate 
CoCl2·6H2O, which is one of the most commonly 
used cobalt compounds in the laboratory 
(Greenwood et al., 1997). Cobalt is mainly found in 
the corrin ring of vitamin B12 (also known as 
cobalamin) and also supports metabolic and red 
blood processes (Chang et al., 2010). Cobalt(II) 
chloride has been used in the treatment and 
prevention of diseases of humans since ancient 
times. It has been known for 45 years that small 
doses of cobalt produce polycythemia in many 
types of animals, including humans (Devlin et al., 
1967). In 1976, Duckham was investigated about 
the treatment of refractory anemia of chronic renal 
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failure with cobalt chloride. The research has 
shown that cobalt is a useful addition to the 
available therapy in the management of the 
refractory anemia of chronic renal failure 
(Duckham et al., 1975). Enteric-coated cobalt 
chloride 25 mg twice daily is recommended for 12 
weeks. The anemia will respond in the majority of 
patients during this time. It appears that within this 
period of treatment, the serum cobalt levels will 
reach a peak and level off. They suggest that either 
the maintenance dose of cobalt chloride is reduced 
to 25mg daily or that courses of three months be 
given intermittently. 
In a previous study, Dutta et al. investigated 
the coordination of different ligands to copper (II), 
and cobalt(III) metal centers enhance the Zika virus 
and dengue virus loads in both arthropod cells and 
human keratinocytes (Dutta et al., 2017). These 
findings suggest that the use of Cu(II) or Co(III) 
conjugation to organic compounds, in insect 
repellents and/or food additives could enhance 
DENV-2/ZIKV loads in human cells and perhaps 
induce pathogenesis in infected individuals or 
individuals pre-exposed to such conjugated 
complexes. However, there are just published data 
about anti-DENV type 2 activities of cobalt 
compounds. Therefore, the research aimed to 
determine the antiviral activity of Cobalt(II) 
chloride against dengue virus type 1 and the 
cytotoxicity of Cobalt(II) chloride to Vero cell. 
 
MATERIALS AND METHODS 
The chemical reagents used in this research 
were the Cobalt(II)-chloride (Sigma-Aldrich, 
Germany), dimethyl sulfoxide (Merck 99.98%, 
Germany), Minimum Essential Eagle Medium 
(Sigma-Aldrich, Germany), Dengue virus serotype 1 
Surabaya Isolate (AB915377), Methanol (Merck 
99.98%, Germany), Vero cell (African green 
monkey kidney), Viral ToxGlo Assay (Promega, 
USA), and Cell Proliferation Reagent WST-1 (Roche 
Applied Science). 
 
Antiviral activity assay 
Vero Cells with concentration 1x106sel/10 
mL were seeded into a 96 well plate and incubated 
plates containing cells at 37°C in a humidified CO2 
incubator for at least 4h (and up to 24h) to facilitate 
attachment and allow cells to recover from seeding 
stresses. One hundred microliters of Dengue                  
virus with concentration 4x105FFU/mL stock           
were combined with various concentrations                      
of   CoCl2.  The   concentrations    of    CoCl2    used   in                    
this study are 50µg/mL 25µg/mL, 12.5µg/mL, 
6.25µg/mL, 3.13µg/mL, 1.56µg/mL (Zandi, 2011). 
After one hour of exposure to the dengue virus at 
room temperature, 100μL of the CoCl2 treated virus 
was added to Vero cells in individual wells. Cells 
were infected for 24h. The unabsorbed virus was 
removed and replaced with MEM. Twenty-four 
hours post-infection 100μL of Viral ToxGlo. 100μL 
of ATP Detection Reagent was added to each well of 
a 96-well plate (25μL to each well of a 384-well 
plate) and wait at least 10min before measuring 
luminescence. Calculate IC50 values by plotting net 
RLU values (subtracting the average of blank wells) 
versus compound concentration. The IC50 value is 
the compound concentration that produced a 50% 
increase in ATP levels compared to virus and no-
virus controls. 
 
In vitro cytotoxicity assay 
Cytotoxicity used WST-1 cell proliferation 
reagent by Roche Applied Science, Mannheim, 
Germany. The assay is very sensitive: it can detect 
1,000 cells/well of a 96-well plate reader. Vero cells 
(1×105cells/mL), 500μL of serial dilution 
compound, and a total of 10μL of Cell Proliferation 
Reagent was added to each well of a 96-well plate 
and incubated under 5% CO2 at 37°C for 1h. The 
various concentration of CoCl2 are 50µg/mL 
25µg/mL, 12.5µg/mL, 6.25µg/mL, 3.13µg/mL, 
1.56µg/mL (Zandi, 2011). The plate was read at 
450nm (main filter) and 655 nm (reference filter) 
using an iMarkTM Microplate Absorbance Reader.  
 
RESULT AND DISCUSSION 
Antiviral activity 
Antiviral activity is a homogeneous, add-
mix-measure method intended that used in 
research studies to identify cytopathic effect (CPE) 
induced by a viral infection. Viral ToxGlo assay a 
more accurate quantitative measure of viral 
inhibition. Cells were either incubated with MEM, 
infected with dengue virus, or infected with CoCl2 
treated dengue virus. A significant inhibitory 
activity to that of the complex Cobalt (II) chloride 
was displayed against the tested pathogenic DENV-
1 in Vero cells. In the inhibitory activity test, we 
studied the ability of the compound to produce a 
direct virus-inactivating effect. The basis of this test 
is the measurement of the ability of living cells 
based on mitochondrial activity from cell culture. 
This method is based on the ATP generated by 
active cells on a live-cell. Microplate reader 
calculated   the   live-cell  after   incubation  for  24h.  
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The percentage inhibition of the development of 
dengue virus type-1 by the test sample of Co (II) 
chloride are presented on the figure (Figure 1). 
 
 
 
Figure 1. Inactivation of DENV-1 at variation 
concentrations of Cobalt(II) chloride  
  
The mechanism analogy of inhibition DENV-
2 from the previous study, it is also possible that an 
intact compound can diffuse across the cell 
membrane or virus capsid, or that Co(II) solute can 
enter cells through the transport and ion/voltage-
gated channels. While Co(II) themselves can 
interact with oxidative organelles or redox-active 
protein to induce reactive oxygen species (ROS) in 
cells, Co(II) produced can also induce ROS by 
various chemical reactions, and ROS can break DNA 
strands and alter gene expression. Another 
possible mechanism is that Co(II) can chelate with 
biomolecules or dislodge the metal ions in some 
metalloproteins, leading to dysfunctional proteins 
and further cell inactivation (Broglie et al., 2015). 
The IC50 value was determined from the 
concentration-response curve (Figure 1); the IC50 
value was 0.38μg/mL, R2 was 0.9406. Based on the 
value of the IC50 Cobalt(II)-Chloride was a highly 
toxic compound. The antiviral activity of Cobalt has 
been described for distinct viruses. Delehanty et al. 
(2008) investigated the antiviral activity of Co(III)-
hexammine to Sindbis virus replication. Co(III)-
hexammine, significantly inhibited Sindbis virus 
replication in baby hamster kidney (BHK) cells in a 
dose and time-dependent manner. In plaque 
assays, the incubation of Co(III)-hexammine with 
Sindbis virus resulted in a dose-dependent 
decrease in virus replication when measured at 
both 24 and 48h post-infection Over the 
concentration range of 0–5mM Co(III)-hexammine, 
the IC50 for the inhibition of viral replication was 
determined to be 0.10±0.04mM at 48h. Analysis by 
flow cytometry confirmed that Co(III) hexammine 
mediated a concomitant dose-dependent increase 
in BHK cell viability and a decrease in the 
percentage of Sindbis virus-infected cells 
(IC50=0.13±0.04mM). These research findings 
demonstrate for the first time that Co(III) 
hexammine possesses potent antiviral activity 
(Delehanty et al., 2008). 
In the previous study, the majority of the 
inorganic ions tested enhanced the anti-herpes 
simplex virus type 1 (HSV-1) activity, EC50 
(effective concentration) of ZnCl2, CuCl2, and FeCl3 
were 1.430µM, 121µM, and 35.8µM. All cations 
tested showed higher antiviral activity except for 
zinc. The mechanism of action was not determined 
during study, but evidence suggests that these 
chelates may target the extracellular attachment 
between the virion glycoprotein B and the heparin 
sulfate proteoglycans on the cells’ surface 
(Langland et al., 2018). The result of Co(III) 
complexes containing N, O donor ligands activity 
for HSV-1 has inhibited replication virus with as 
little as 5µg/mL required for active antiviral (Chang 
et al., 2010). Many different metal ions are required 
to support the metabolism of cells. The suggestion 
has been made that all nucleotidyl transferases are 
metalloenzymes, and the involvement of zinc ions 
in both DNA and RNA polymerases is well 
documented. The attachment of a copper complex 
to an mRNA that is synthesized late in the infective 
cycle of viruses would affect the function of the 
mRNA, and this may account for the antiviral 
activity of these compounds (Hutchinson, 1985).  
 
 
 
 
Figure 2 Cytotoxicity of Cobalt (II) chloride for Vero 
Cells at variation concentrations 
 
Cytotoxicity of Cobalt(II) chloride to Vero Cell 
Cobalt (II) chloride was screened for its 
cytotoxicity against Vero cells at different 
concentrations to determine the CC50 by WST-1 
assay. The CC50 value was found to increase with an 
increasing concentration of the test compound 
(Figure 2). The CC50 of Cobalt (II) chloride for Vero 
cells was 2.91µg/mL. In this study, we have 
examined the relationship between the 
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concentration of Vero cells in the culture medium 
and the cytotoxic potency of Cobalt(II)–chloride. 
In the previous study, Sucipto et al. 
investigated the antiviral activity of Copper(II) 
chloride dehydrate against dengue virus type-2 in 
Vero cell. It has been revealed that Co(II) is more 
toxic than Cu(II) with a CC50 value of 5.03μg/mL 
(Sucipto et al., 2017). Copper(II) was non-toxic to 
human erythrocyte cells even at a concentration of 
500μg/mL (Lv et al., 2006). The effects of metal 
solutions containing Al(III), Cd(II), Hg(II), and 
Pb(II) to Vero cells were 6.25, 0.83, 3.7, 2.9, and 
3.4µg/mL respectively (Traoré et al., 1999). The 
CoCl2.6H2O being the most effective 
antiproliferative agent, hence it was further tested 
against cancer cells and induced maximum cell 
death in IMR-32 followed by PC-3 and A549 with 
values of 7.12, 21.91, and 29.81μg/mL respectively 
(Mahey et al., 2016). Thus, apoptosis was found to 
execute in cells by over generation of ROS (reactive 
oxygen species) and concomitant damage to the 
mitochondrial membrane. 
For Vero cells incubated with 
polyoxometalate-stabilized gold nanoparticles for 
24h was from 20-100µg/mL, approximately 93-
95% was shown to be alive, 0.1-0.3% apoptotic. 
This data is commensurate with little or no toxicity 
when compared to the control sample (Gabas et al., 
2016). The synthesis of metal silver nanoparticles 
effect to Vero cell lines was found to be 
18.15µg/mL. The cytotoxic effects had indicated 
the occurrence of active physicochemical 
interaction of silver atoms with the functional 
groups of intracellular proteins, as well as with the 
nitrogen bases and phosphate groups in DNA 
(Prasannaraj et al., 2017).  
   
CONCLUSION 
Cobalt(II) chloride was shown to have 
antiviral activity against DENV-1, a member of the 
Flavivirus genus, in vitro. Antiviral activity results 
suggest that the IC50 value was 0.38 μg/ml. 
Cytotoxicity of Cobalt(II) chloride to Vero cell 
suggests that the CC50 value was 2.91 µg/ml. Based 
on the value of the IC50 and CC50 value, Cobalt(II) 
chloride was a highly toxic compound. 
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